Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Naples
Clinical trial register · Italy

Clinical Trials in Naples, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca79 Hoffmann-La Roche48 Merck Sharp & Dohme LLC40 Bristol-Myers Squibb37 National Cancer Institute, Naples36
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Naples

983 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Sanofi
Observational
230
Bologna, Brescia, Florence, Milan, Naples, Roma, Verona
2023-11-30
Recruiting
Novartis Pharmaceuticals
Phase 2/3
232
Bologna, Milan, Roma, Torino, Naples
2023-11-24
Recruiting
AstraZeneca
Phase 3
625
Bergamo, Empoli, Milan, Modena, Naples, Padova, Reggio Emilia, Roma
2023-11-23
Active, closed
AstraZeneca
Phase 3
1,898
Bari, Genoa, Meldola, Milan, Naples, Padova, Rome, Rozzano
2023-11-21
Recruiting
Naples Federico II Intensive Cardiac Care Unit Registry (Naples FED2-ICCU Registry)
NCT06162247Acute Cardiovascular Disease, Acute Coronary Syndrome, Acute Heart Failure, Cardiogenic Shock
Federico II University
Observational
5,000
Naples
2023-11-20
Recruiting
CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine
NCT06158698Cardiomyopathies, Myocarditis, Inflammatory Cardiomyopathy, Heart Failure
DrugColchicine
Niguarda Hospital
Phase 3
80
Naples, Bologna, Trieste, Udine, Rome, Milan, Turin, Ancona
2023-11-14
Active, closed
AstraZeneca
Phase 3
1,902
Empoli, Lucca, Milan, Modena, Naples, Padova, Province of Macerata, Roma
2023-11-14
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Meldola, Turin, Palermo, Milan, Modena, Naples, Perugia, Pisa
2023-11-14
Active, closed
GlaxoSmithKline
Phase 2
316
Rozzano, Bari, Bologna, Florence, Genova, Milan, Naples, Novara
2023-11-14
Recruiting
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
NCT06128551Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
DrugsElironrasib·Cetuximab
Revolution Medicines, Inc.
Phase 1/2
534
Verona, Ancona, Aviano, Meldola, Milan, Naples, Orbassano, Ravenna
2023-11-14
Active, closed
AstraZeneca
Phase 3
1,835
Bergamo, Bologna, Foggia, Genoa, Naples, Pisa, Roma, Torino
2023-11-07
Active, closed
Bristol-Myers Squibb
Phase 2
227
Naples, San Donato Milanese, Pisa, Bergamo
2023-11-07
Active, closed
Bristol-Myers Squibb
Phase 2
100
Bergamo, Meldola, Milan, Padova, Roma, Torino, Naples
2023-11-06
Recruiting
Federico II University
Phase 4
80
Ferrara, Naples
2023-11-01
Recruiting
LeonaBio
Phase 3
600
Ancona, Aviano, Candiolo, Meldola, Milan, Misterbianco, Modena, Naples
2023-10-31
Active, closed
IDEAYA Biosciences
Phase 2/3
420
Milan, Naples, Roma, Siena
2023-10-31
Recruiting
PRO for Fighting FT in Ovarian Cancer
NCT06032975Ovarian Cancer
National Cancer Institute, Naples
Observational
240
Naples
2023-10-30
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Ancona, Milan, Salerno, Naples
2023-10-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Monserrato, San Giovanni Rotondo, Rome, Milan, Rozzano, Rho, Naples, Palermo
2023-10-25
Recruiting
Potential Role of Sirtuins As Epigenetic Biomarkers of the Patient with Atherosclerosis or Calcific Aortic Stenosis
NCT06337227Atherosclerosis and Calcific Aortic Stenosis with and Without Diabetes
IRCCS SYNLAB SDN
Observational
3
Naples
2023-10-19
Recruiting
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
NCT06026410Solid Tumors With HRAS Alterations, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC)
DrugsAdagrasib·Cabozantinib
Kura Oncology, Inc.
Phase 1
300
Bologna, Candiolo, Naples, Rozzano, Verona
2023-10-18
Active, closed
Ipsen
Phase 3
759
Bologna, Naples, Pavia, Pozzilli, Roma
2023-10-12
Recruiting
AbbVie
Phase 3
1,500
Florence, L’Aquila, Rozzano, Naples, Rome, Bologna, Brescia, Catania
2023-10-11
Active, closed
Bristol-Myers Squibb
Observational
404
Naples
2023-10-11
Active, closed
Bristol-Myers Squibb
Phase 3
106
Reggio Calabria, Naples, Rome, Pavia, Rozzano (MI), Novara, Turin, Florence
2023-10-05
Recruiting
Novartis Pharmaceuticals
Phase 3
106
Bari, Ranica, Brescia, Milan, Roma, Torino, Naples
2023-10-02
Recruiting
Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
NCT06236464Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma of the Anus
National Cancer Institute, Naples
Observational
170
Bari, Naples, Novara, Pisa
2023-09-25
Recruiting
AstraZeneca
Phase 3
800
Bari, Bologna, Catania, Florence, Lecco, Milan, Monza, Naples
2023-09-22
Active, closed
AbbVie
Phase 2
130
Florence, Milan, Naples, Bologna, Palermo, Roma
2023-09-21
Active, closed
PharmaMar
Phase 3
469
Rozzano, Naples, Aviano, Bologna, Candiolo, Orbassano, Padova, Palermo
2023-09-21
Active, closed
Bayer
Phase 1
232
Milan, Naples
2023-09-20
Recruiting
Aesculap AG
Observational
2,998
Naples
2023-09-18
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Naples, Bologna, Modena, Genoa, Bergamo, Milan, Rozzano, Catania
2023-09-18
Recruiting
Regina Elena Cancer Institute
Phase 3
158
Rome, Naples
2023-09-15
Active, closed
Bristol-Myers Squibb
Phase 3
774
Brescia, Milan, Naples, Pisa, Rome, Udine
2023-09-11
Recruiting
Glycemic Response to Carbob-Enriched Pasta in Healthy and With Type 1 Diabetes People
NCT06994403Glycemic and Insulinemic Response, Type 1 Diabetes (T1D)
Federico II University
Not applicable
10
Naples
2023-09-04
Active, closed
National Cancer Institute, Naples
Observational
112
Naples
2023-09-04
Recruiting
National Cancer Institute, Naples
Phase 2
38
Naples, Roma, Torino, Verona
2023-09-01
Recruiting
Ipsen
Phase 3
276
Modena, Monza, Naples, Padova, Palermo, Pavia, Pisa, San Giovanni Rotondo
2023-08-31
Active, closed
Cytokinetics
Phase 3
500
San Donato Milanese, Brescia, Florence, Foggia, Milan, Naples, Pisa, Roma
2023-08-31
Active, closed
Emalex Biosciences Inc.
Phase 3
150
Genova, Naples, Roma, Catania, Milan
2023-08-16
Active, closed
Pfizer
Phase 3
59
Naples, Meldola, Monza
2023-08-09
Active, closed
Hoffmann-La Roche
Phase 3
459
Bari, Naples, Bologna, Rome, Genoa, Pavia, Turin
2023-08-08
Recruiting
Ponatinib in Chronic Myeloid Leukemia Patients in Chronic Phase
NCT06119269Chronic Myeloid Leukemia, Chronic Phase
University of Pisa
Observational
100
Cagliari, Milan, Naples, Pisa, Roma
2023-08-02
Recruiting
GlaxoSmithKline
Phase 3
892
Cagliari, Genova, Milan, Naples, Padova, Pisa, Reggio Emilia, Roma
2023-08-01
Recruiting
Istituto Auxologico Italiano
Observational
1,000
Milan, Naples
2023-08-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Milan, Siena, Perugia, Naples
2023-07-19
Recruiting
Amicus Therapeutics
Phase 3
36
Naples
2023-07-18
Active, closed
University of Campania Luigi Vanvitelli
Observational
128
Naples
2023-07-18
Recruiting
The ONCOCAMP Study
NCT06270602Oncology
National Cancer Institute, Naples
Observational
15,000
Avellino, Benevento, Caserta, Casavatore, Ercolano, Naples, Salerno
2023-07-14
Recruiting
Meyer Children's Hospital IRCCS
Not applicable
300
Florence, Naples, Palermo
2023-07-06
Recruiting
National Cancer Institute, Naples
Observational
3,100
Naples
2023-07-06
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
383
Bari, Foggia, Naples, Modena, Trieste, Pavia, Ranica
2023-07-06
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Naples, Cona, Ferrara, Pavia, Catania, Palermo
2023-06-28
Active, closed
OncoC4, Inc.
Phase 3
630
Ancona, Bari, Bergamo, Catania, Milan, Monza, Naples, Palermo
2023-06-28
Active, closed
AstraZeneca
Phase 3
111
Milan, Naples, Padova, Pisa, Rozzano, Turin
2023-06-27
Recruiting
University of Campania Luigi Vanvitelli
Not applicable
30
Naples
2023-06-24
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
390
Naples, Milan
2023-06-23
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Catania, Florence, Genova, Milan, Pisa, Roma, Torino, Naples
2023-06-22
Active, closed
Exact Sciences Corporation
Observational
416
Rozzano, Milan, Naples
2023-06-20
Recruiting
Hoffmann-La Roche
Phase 1/2
320
Naples, Rome, Milan, Orbassano
2023-06-20
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
100
Bologna, Rozzano, Palermo, Genova, Milan, Modena, Naples, Padova
2023-06-19
Recruiting
ModernaTX, Inc.
Observational
60
Naples, Monza, Florence
2023-06-16
Recruiting
National Cancer Institute, Naples
Phase 2
240
Naples, Milan, Roma, Verona
2023-06-12
Recruiting
A.O.U. Città della Salute e della Scienza
Observational
200
Milan, Naples, Torino
2023-05-20
Recruiting
Pfizer
Phase 2
100
Naples, Genoa, Monza, Rome, Catania, Padova, Pavia, Torino
2023-05-17
Recruiting
Takeda
Phase 3
240
Naples, Bologna, Rome, Monza, Florence, Padova
2023-05-16
Recruiting
Novartis Pharmaceuticals
Phase 3
200
Brescia, Catania, Florence, Pavia, Roma, Naples
2023-05-11
Active, closed
A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
NCT05789069Renal Cell Carcinoma, Melanoma, Non Small Cell Lung Cancer, Gastric Cancer
DrugTislelizumab
HiFiBiO Therapeutics
Phase 1
83
Naples, Rome, Verona
2023-05-09
Active, closed
Servier Affaires Médicales
Phase 3
299
Bologna, Florence, Milan, Naples, Reggio Emilia, Roma, Rozzano, San Giovanni Rotondo
2023-05-03
Active, closed
AstraZeneca
Phase 2
294
Florence, Milan, Naples, Rozzano
2023-04-24
Active, closed
Karyopharm Therapeutics Inc
Phase 3
257
Bologna, Brescia, Meldola, Milan, Monza, Naples, Padova, Pisa
2023-04-18
Active, closed
Hoffmann-La Roche
Phase 2
204
Bari, Naples, Bologna, Meldola, Rome, Milan, Terni, Padova
2023-04-13
Recruiting
Federico II University
Observational
100
Naples
2023-04-12
Active, closed
Alfasigma S.p.A.
Phase 3
495
Bologna, Naples, Palermo, Rome, Udine
2023-04-05
Active, closed
Sanofi
Phase 2
999
Milan, Naples, Rome, Brescia, Vicenza
2023-04-03
Active, closed
Bayer
Phase 3
985
Foggia, Naples, Bologna, Modena, Reggio Emilia, Aviano, Rome, Genoa
2023-04-03
Recruiting
Istituto Superiore di Sanità
Observational
296
Como, Milan, Naples, Rome
2023-04-01
Not yet open
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
300
Naples, Roma
2023-04-01
Active, closed
Bial R&D Investments, S.A.
Phase 2
237
Bologna, Brescia, Brindisi, Milan, Naples, Padova, Roma, Rozzano
2023-03-31
Active, closed
IRCCS SYNLAB SDN
Observational
100
Naples
2023-03-31
Recruiting
Iovance Biotherapeutics, Inc.
Phase 3
670
Meldola, Aviano, Naples, Pisa, Milan, Siena
2023-03-30
Recruiting
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2
60
Meldola, Monza, Pesaro, Bari, Bologna, Naples, Padova, Ravenna
2023-03-27
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Acquaviva delle Fonti, Asti, Avellino, Castelfranco Veneto, Milan, Naples, Ravenna, Rome
2023-03-23
Recruiting
United Pharmaceuticals
Not applicable
346
Naples
2023-03-17
Active, closed
AbbVie
Phase 3
520
Florence, Meldola, Genoa, Rozzano, Milan, Naples, Rome, Mirano
2023-03-15
Recruiting
IRCCS SYNLAB SDN
Observational
80
Naples
2023-03-13
Active, closed
AstraZeneca
Phase 2
188
Avellino, Brescia, Lecce, Milan, Naples, Palermo, Peschiera del Garda, Reggio Emilia
2023-03-06
Active, closed
Bristol-Myers Squibb
Phase 3
579
Genova, Siena, Bari, Milan, Naples, Perugia, Roma
2023-03-06
Active, closed
Pfizer
Phase 3
624
Naples, Misterbianco, Bologna, Cona, Rome, Monza, Ancona, Pisa
2023-03-03
Active, closed
AstraZeneca
Observational
551
Naples, Cona, Udine, Rome, Brescia, Milan, Turin, Cagliari
2023-02-27
Active, closed
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
NCT05566795Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, Pediatric Low-grade Glioma
DrugsTovorafenib·Carboplatin
Day One Biopharmaceuticals, Inc.
Phase 3
418
Milan, Roma, Torino, Bari, Florence, Genova, Naples, Padova
2023-02-27
Active, closed
Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application
NCT05094089Hernia, Ventral, Hernia Incisional, Hernia Incisional Ventral
W.L.Gore & Associates
Observational
320
Baggiovara, Naples, Roma
2023-02-24
Recruiting
Fore Biotherapeutics
Phase 2
254
Meldola, Naples, Milan
2023-02-21
Recruiting
Post-Market Registry for the Evaluation of RefluxStop in GERD Treatment
NCT05870163Gastroesophageal Reflux Disease (GERD)
Implantica CE Reflux Ltd.
Observational
2,500
Bari, Naples
2023-02-20
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Rome, Florence, Milan, Naples, Roma, Torino
2023-02-13
Active, closed
Genmab
Phase 3
900
Alessandria, Bari, Brescia, Bologna, San Giovanni Rotondo, Milan, Naples, Palermo
2023-02-08
Active, closed
Merck Sharp & Dohme LLC
Phase 3
614
Rome, Bergamo, Milan, Naples, Florence, Peschiera del Garda, Parma
2023-02-06
Recruiting
START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
NCT05492682Melanoma (Skin), Triple-Negative Breast Cancer, Non-Small Cell Lung Cancer, Synovial Sarcoma
DrugsCyclophosphamide·Pembrolizumab
Valo Therapeutics Oy
Phase 1
15
Candiolo, Milan, Naples
2023-02-02
Recruiting
Istituto Clinico Humanitas
Not applicable
146
Brescia, Florence, Rozzano, Milan, Naples, Rome, Terni
2023-01-31
Active, closed
Stemline Therapeutics, Inc.
Phase 1/2
435
Brescia, Milan, Naples, Rimini
2023-01-24
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,564
Ancona, Naples, Meldola, Milan, Bari, Cuneo, Perugia, Rome
2023-01-16
Active, closed
Bristol-Myers Squibb
Phase 3
516
Rome, Milan, Pisa, Padova, Brescia, Naples, Verona
2023-01-12
Recruiting
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
NCT05378347Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)
Medtronic Cardiovascular
Not applicable
600
Milan, Naples, Torino
2023-01-05
Recruiting
National Cancer Institute, Naples
Observational
70
Naples
2023-01-02
Recruiting
AF Ablation With High Power Short Duration RF
NCT05777551Atrial Fibrillation, Catheter Ablation
Clinica Mediterranea
Observational
850
Mercogliano, Cotignola, Conegliano, Ancona, Asti, Naples, Torino
2023-01-01
Recruiting
Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer
NCT06783127Prostate Cancer, Castrate Resistant Prostate Cancer, BRCA Mutation
DrugOlaparib
Santa Chiara Hospital
Observational
3,000
Naples, Trento
2023-01-01
Active, closed
Exelixis
Phase 3
317
Rozzano, Candiolo, Arezzo, Bari, Brescia, Meldola, Milan, Naples
2023-01-01
Active, closed
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
NCT05024773Bladder Carcinoma in Situ (CIS)
Fidia Farmaceutici s.p.a.
Phase 3
130
Bergamo, Bologna, Castelfranco Veneto, Florence, Lecce, Milan, Naples, Roma
2022-12-29
Active, closed
Hoffmann-La Roche
Phase 3
1,290
Battipaglia, Naples, Ferrara, Pavia, Catania, Palermo
2022-12-29
Active, closed
AstraZeneca
Phase 3
1,350
Florence, Lecco, Messina, Naples, Orbassano, Padova, Parma, Peschiera del Garda
2022-12-29
By invitation
Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
NCT05396105Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II, Hereditary Angioedema Types I and II
DrugDeucrictibant
Pharvaris Netherlands B.V.
Phase 2/3
150
Catania, Milan, Naples, Padova, Palermo, Roma
2022-12-28
Recruiting
Meyer Children's Hospital IRCCS
Observational
1,000
Florence, Bari, Belluno, Bologna, Genova, Milan, Modena, Naples
2022-12-22
Recruiting
Immunocore Ltd
Phase 3
540
Milan, Naples, Perugia, Roma, Siena
2022-12-19
Recruiting
Greenwich LifeSciences, Inc.
Phase 3
2,250
Bologna, Genova, Milan, Modena, Naples, Novara, Padova, Pavia
2022-12-16
Recruiting
IFOM ETS - The AIRC Institute of Molecular Oncology
Phase 2
37
Novara, Bergamo, Milan, Naples, Padova, Reggio Emilia
2022-12-15
Recruiting
Princess Maxima Center for Pediatric Oncology
Phase 3
160
Florence, Naples, Roma, Torino, Trieste, Verona
2022-12-15
Recruiting
AstraZeneca
Phase 3
3,527
Arezzo, Brescia, Naples, Roma, Rozzano, Torino
2022-12-13
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
885
Bergamo, Bologna, Caserta, Milan, Naples, Palmero, Rome
2022-12-13
Active, closed
Janssen Research & Development, LLC
Phase 1/2
57
Milan, Naples, Padova, Ravenna, Rome
2022-12-13
Active, closed
Agenus Inc.
Phase 2
150
Meldola, Naples, Siena
2022-12-12
Active, closed
Bristol-Myers Squibb
Phase 2
189
Genova, Orbassano, Naples
2022-12-09
Active, closed
University Hospital, Tours
Not applicable
35
Naples
2022-12-05
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
180
Naples, Padova, Perugia, Roma, Rome, Siena
2022-11-30
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 3
297
Ancona, Florence, Genova, Messina, Milan, Naples, Orbassano, Potenza
2022-11-23
Active, closed
National Cancer Institute, Naples
Phase 1
10
Naples
2022-11-22
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
260
Bergamo, Brescia, Florence, Milan, Naples, Palermo, Pisa, Roma
2022-11-21
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
Chieti, Bari, Catanzaro, Naples, Udine, Rome, Genoa, Bergamo
2022-11-21
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
48
Milan, Naples
2022-11-16
Recruiting
Janssen Research & Development, LLC
Phase 2
520
Genova, Milan, Monza, Naples
2022-11-11
Active, closed
AstraZeneca
Phase 3
368
Bologna, Milan, Naples, Padova, Pisa, Roma, Rozzano, Verona
2022-11-10
Active, closed
Safety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid Leukemia
NCT07232953Acute Myeloid Leukaemia (AML), Hematopoietic Stem Cell Transplant (HSCT)
DrugsTreosulfan·Fludarabine
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Phase 2
82
Reggio Calabria, Naples, Modena, Udine, Brescia, Milan, Cuneo, Ancona
2022-11-10
Recruiting
The Use of Indocyanine Green Fluorescence (ICG) During Laparoscopic Heller- Dor
NCT07181070Achalasia, Esophageal, Achalasia, Indocyanine Green (ICG), Indocyanine Green
Federico II University
Observational
70
Naples
2022-11-01
Recruiting
Federico II University
Observational
3,000
Naples
2022-11-01
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Bergamo, Bologna, Florence, Milan, Naples, Pavia, Roma, Rozzano
2022-10-25
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
400
Monserrato, Avellino, Rome, Tricase, Brescia, Milan, Naples, Verona
2022-10-24
Active, closed
Almirall, S.A.
Phase 4
447
Arezzo, Brescia, Genova, Modena, Naples, Reggio Emilia, Roma, Rozzano
2022-10-24
Active, closed
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
NCT05587296Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
Bayer
Phase 3
474
Naples, Modena, Rome, Genoa, Milan, Pavia, Turin, Florence
2022-10-14
Active, closed
Gilead Sciences
Phase 3
1,021
Avellino, Cremona, Genova, Milan, Naples, Pavia, Pesaro, Piacenza
2022-10-12
Recruiting
EMD Serono Research & Development Institute, Inc.
Observational
700
Misterbianco, Milan, Modena, Naples, Rome, Torino, Varese
2022-10-04
Recruiting
Federico II University
Observational
3,000
Naples
2022-10-01
Active, closed
Hoffmann-La Roche
Phase 3
122
Naples, Genoa, Pavia, Palermo
2022-09-27
Recruiting
Janssen Research & Development, LLC
Phase 2/3
201
Catania, Genova, Milan, Naples, Orbassano, Pavia, Roma, Rozzano
2022-09-23
Recruiting
INSIGHTFUL-FFR Clinical Trial
NCT05437900Coronary Artery Disease, Acute Coronary Syndrome
CoreAalst BV
Phase 4
2,500
Ferrara, La Spezia, Latina, Naples, Rome
2022-09-22
Active, closed
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
NCT05462717Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor
DrugElironrasib
Revolution Medicines, Inc.
Phase 1
222
Milan, Naples, Orbassano, Pavia, Verona
2022-09-19
Active, closed
Evaxion Biotech A/S
Phase 2
17
Milan, Naples
2022-09-19
Active, closed
AstraZeneca
Phase 3
594
Aviano, Livorno, Meldola, Milan, Monza, Naples, Padova, Parma
2022-09-15
Active, closed
Biogen
Phase 2/3
450
Bologna, Brescia, Florence, Genova, Milan, Naples, Roma
2022-09-13
Active, closed
VisionCare, Inc.
Not applicable
68
Naples, Roma
2022-09-13
Recruiting
University of Milano Bicocca
Observational
500
Bari, Bologna, Brescia, Catania, Naples, Roma, Torino, Udine
2022-09-08
Recruiting
AstraZeneca
Phase 2
454
Florence, Genova, Milan, Naples, Rome
2022-09-06
Recruiting
GlaxoSmithKline
Phase 3
109
Bologna, Catania, Milan, Naples, Novara, Pavia, Roma, Treviso
2022-09-06
Recruiting
Stemline Therapeutics, Inc.
Phase 1/2
73
Ancona, Candiolo, Meldola, Messina, Milan, Modena, Monza, Naples
2022-08-31
Recruiting
Asciminib Roll-over Study
NCT04877522Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive
DrugsAsciminib single agent·Bosutinib·ABL001·Nilotinib
Novartis Pharmaceuticals
Phase 4
347
Milan, Roma, Naples
2022-08-30
Recruiting
Acrivon Therapeutics
Phase 2
350
Aviano, Catania, Milan, Naples, Pieve Emanuele, Roma, Turin
2022-08-29
Active, closed
Sanofi
Phase 2/3
1,856
Milan, Rozzano, Naples, Rome, Turin, Bologna, Catania, Chieti
2022-08-22
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 2
256
Bologna, Florence, Forlì, Milan, Misterbianco, Naples, Padova, Pisa
2022-08-17
Active, closed
AbbVie
Observational
785
Castellana Grotte, Rozzano, Milan, Naples, Rome, Negrar, Palermo, Pisa
2022-08-15
Active, closed
AstraZeneca
Phase 2
194
Candiolo, Milan, Naples, Padova, Perugia, Roma, Siena
2022-08-11
Active, closed
Novo Nordisk A/S
Phase 3
412
Milan, Florence, Genova, Naples, Roma, Rome
2022-08-10
Active, closed
Novartis Pharmaceuticals
Phase 3
506
Ancona, Milan, Salerno, Udine, Naples
2022-08-04
Active, closed
AstraZeneca
Phase 3
341
Avellino, Aviano, Catania, Meldola, Milan, Modena, Monserrato, Naples
2022-08-03
Active, closed
Bausch Health Americas, Inc.
Phase 3
466
Milan, Naples, Novara, Palermo, Rozzano
2022-08-03
Recruiting
D3 Bio (Wuxi) Co., Ltd
Phase 1/2
442
Candiolo, Milan, Naples, Rome, Siena
2022-08-03
Active, closed
Eli Lilly and Company
Phase 4
780
Bari, Naples, Milan, Moncalieri, Olbia, Palermo, Pisa, Catanzaro
2022-08-01
Recruiting
Research Maatschap Cardiologen Rotterdam Zuid
Phase 4
1,656
Bergamo, Ferrara, Genova, Milan, Naples, Roma
2022-07-22
Active, closed
Hoffmann-La Roche
Phase 3
922
Naples, Reggio Emilia, Rimini, Rome, Brescia, Milan, Rozzano, Misterbianco (CT)
2022-07-18
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Naples, San Giovanni Rotondo, Genoa, Rozzano, Candiolo, Pisa, Bari, Brescia
2022-07-14
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
154
Catania, Naples, Padova, Palermo, San Donato Milanese
2022-07-13
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
28
Ancona, Aviano, Florence, Miano, Monza, Naples, Roma, Palermo
2022-07-11
Active, closed
Pfizer
Phase 2
108
Monserrato, Naples, Guastalla, San Giovanni Rotondo, Milan, Candiolo, Livorno, Pisa
2022-07-11
Active, closed
Incyte Corporation
Phase 1
291
Milan, Naples, Rome, Rozzano, Verona
2022-07-05
Recruiting
Pfizer
Phase 4
210
Bari, Perugia, Rome, Candiolo, Padova, Bologna, Milan, Naples
2022-07-05
Active, closed
AstraZeneca
Phase 3
53
Messina, Naples, Roma
2022-07-01
Active, closed
Hoffmann-La Roche
Phase 4
136
Naples, Rome, Milan, Florence
2022-06-20
Active, closed
RECORDATI GROUP
Observational
206
Ancona, Milan, Naples, Roma
2022-06-13
Recruiting
BioMarin Pharmaceutical
Observational
450
Bologna, Florence, Milan, Naples, Padova, Palermo, Rome
2022-06-06
Recruiting
A Multicenter Study for Evaluating a Digital Support System in Childhood Obesity Treatment
NCT04917601Childhood Obesity, Adolescent Obesity, mHealth, Personalized Medicine
Karolinska Institutet
Not applicable
680
Messina, Naples
2022-05-24
Recruiting
National Cancer Institute, Naples
Observational
300
Naples, Roma
2022-05-19
Active, closed
IO Biotech
Phase 3
407
Ancona, Aviano, Bari, Candiolo, Genova, Meldola, Milan, Naples
2022-05-17
Active, closed
AstraZeneca
Phase 3
644
Borgo San Lorenzo, Catanzaro, Genova, Livorno, Milan, Modena, Naples, Province of Macerata
2022-05-16
Recruiting
Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
NCT06516406Myelofibrosis, Primary Myelofibrosis, Secondary Myelofibrosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,055
Cosenza, Reggio Calabria, Naples, Bologna, Ferrara, Parma, Piacenza, Ravenna
2022-05-06
Active, closed
Sanofi
Phase 3
104
Milan, Naples, Bologna
2022-05-03
Active, closed
Pierre Fabre Medicament
Phase 3
815
Meldola, Taormina, Naples, Aviano, Bari, Bergamo, Cuneo, Genova
2022-05-02
By invitation
AI-Enhanced Analysis of Breast Density and Background Parenchymal Enhancement (BPE)
NCT06838130Breast Parenchimal Enhancement, Artificial Intelligence (AI)
Link Campus University
Observational
213
Naples
2022-05-01
Recruiting
UNICANCER
Phase 3
300
Bari, Candiolo, Foggia, Meldola, Milan, Naples, Roma, Rozzano
2022-04-19
Active, closed
Sanofi
Phase 3
43
Milan, Naples
2022-04-18
Recruiting
AbbVie
Phase 3
768
Misterbianco, Milan, Naples, Rome, Bari, Cremona, Messina, Perugia
2022-03-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
460
Naples, Milan, Rozzano, Rome
2022-03-24
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 2
49
Brescia, Alessandria, Cuneo, Florence, Genova, Milan, Naples, Novara
2022-03-21
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
Bologna, Brescia, Florence, Genova, Messina, Milan, Naples, Pavia
2022-03-15
Active, closed
Sanofi
Phase 3
122
Bologna, Monza, Naples, Palermo, Roma
2022-03-11
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Naples, Genoa, Monza (MB), Catania (CT), Torrette, Trento, Livorno, Prato
2022-03-07
Active, closed
Daiichi Sankyo
Phase 3
740
Bari, Chieti, Lucca, Milan, Naples, Perugia, Rome, Varese
2022-03-04
Active, closed
Janssen Research & Development, LLC
Phase 2
151
Naples, Pavia, Roma
2022-03-01
Recruiting
Naples PCI Registry
NCT05248165Coronary Artery Disease, Percutaneous Coronary Intervention, Myocardial Ischemia, Myocardial Infarction
Federico II University
Observational
5,000
Naples
2022-03-01
Active, closed
AstraZeneca
Phase 3
390
Bari, Catania, Florence, Genova, Milan, Naples, Padova, Parma
2022-02-21
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 2
310
Naples, Modena, Aviano, Rome, Milan, Verona, Bologna
2022-02-17
Recruiting
Sanofi
Phase 3
284
Cona, Florence, Milan, Rozzano, Naples, Rome, Ancona
2022-02-15
Active, closed
Agios Pharmaceuticals, Inc.
Phase 2/3
286
Naples, Modena, Rome, Genoa, Palermo
2022-02-11
Recruiting
Takeda
Phase 3
120
Naples, Bologna, Rome, Monza, Padova
2022-02-10
Active, closed
NewAmsterdam Pharma
Phase 3
9,541
Ferrara, Milan, Naples, Palermo, Pavia, Rozzano, Terni
2022-02-07
Active, closed
Merck Sharp & Dohme LLC
Phase 3
280
Naples, Bologna, Meldola, Milan, Turin, Rome, Florence, Vicenza
2022-02-03
Recruiting
Federico II University
Observational
100
Naples
2022-01-27
Recruiting
Federico II University
Observational
100
Naples
2022-01-27
Recruiting
National Cancer Institute, Naples
Phase 3
200
Naples
2022-01-21
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
290
Rozzano, Bologna, Naples, Roma
2022-01-14
Active, closed
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
NCT05407636AMD, nAMD, Wet Age-related Macular Degeneration, wAMD
DrugsEylea·Aflibercept
AbbVie
Phase 3
735
Cona, Milan, Naples, Rome, Negrar, Bari, Chieti, Udine
2022-01-13
Recruiting
Azienda Ospedaliero-Universitaria Careggi
Observational
10,000
Bari, Bologna, Florence, Foggia, Genova, Messina, Milan, Naples
2022-01-10
Active, closed
Società Italiana Talassemie ed Emoglobinopatie
Observational
1,000
Torino, Cagliari, Ferrara, Genova, Milan, Naples, Palermo, Roma
2022-01-01
Active, closed
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)
NCT04770753Non-Transfusion-dependent Alpha-Thalassemia, Non-Transfusion-dependent Beta-Thalassemia
DrugMitapivat
Agios Pharmaceuticals, Inc.
Phase 3
194
Brindisi, Cagliari, Ferrara, Genova, Milan, Modena, Naples, Orbassano
2021-12-20
Active, closed
Eli Lilly and Company
Phase 3
152
Bari, Milan, Rozzano, Naples, Orbassano, Padova
2021-12-20
Recruiting
Merck Sharp & Dohme LLC
Phase 1
830
Rozzano, Siena, Naples
2021-12-17
Recruiting
RFC1 Natural History Study
NCT05177809Ataxia
Prof. Dr. Matthis Synofzik
Observational
150
Naples, Pisa
2021-12-14
Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
NCT05176483Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor
DrugsZanzalintinib·Relatlimab·Yervoy·Ipilimumab
Exelixis
Phase 1
1,394
Ancona, Bologna, Florence, Milan, Naples, Ravenna
2021-12-14
Active, closed
GlaxoSmithKline
Phase 2
360
Bergamo, Milan, Modena, Naples, Palermo, Pisa
2021-12-14
Active, closed
Novartis Pharmaceuticals
Phase 3
1,007
Brindisi, Foggia, Pozzilli, Messina, Modena, Pavia, Orbassano, Naples
2021-12-13
Active, closed
University Hospital, Basel, Switzerland
Not applicable
543
Bologna, Florence, Naples, Torino
2021-12-09
Active, closed
Agios Pharmaceuticals, Inc.
Phase 3
258
Brindisi, Cagliari, Ferrara, Genova, Milan, Modena, Naples, Orbassano
2021-11-30
Active, closed
Womed
Not applicable
160
Naples, Torino
2021-11-29
Active, closed
AstraZeneca
Phase 3
145
Milan, Naples, Roma
2021-11-19
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
60
Naples, Palermo, Rome
2021-11-18
Active, closed
argenx
Phase 3
173
Ferrara, Milan, Naples
2021-11-17
Active, closed
Amgen
Phase 3
303
Bari, Bergamo, Bologna, Genova, Lecce, Mestre (VE), Milan, Naples
2021-11-02
Active, closed
AstraZeneca
Phase 3
148
Arezzo, Avellino, Bari, Bologna, Florence, Meldola, Milan, Naples
2021-10-28
Active, closed
AstraZeneca
Phase 3
927
Bologna, Candiolo, Livorno, Milan, Naples, Negrar, Padova, Roma
2021-10-25
Recruiting
Hoffmann-La Roche
Phase 1
542
Naples, Meldola, Rome, Milan, Padova
2021-10-22
Active, closed
Boehringer Ingelheim
Phase 1
151
Naples
2021-10-18
Active, closed
AstraZeneca
Phase 3
732
Bologna, Candiolo, Florence, Meldola, Milan, Naples, Padova, Prato
2021-10-18
Active, closed
Study of Vimseltinib for Tenosynovial Giant Cell Tumor
NCT05059262Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath, Tenosynovial Giant Cell Tumor, Diffuse
DrugVimseltinib
Deciphera Pharmaceuticals, LLC
Phase 3
123
Bologna, Milan, Naples, Padua, Rome
2021-10-14
Active, closed
Hoffmann-La Roche
Phase 2
176
Bari, Naples, Rome, Milan
2021-10-07
Recruiting
National Cancer Institute, Naples
Not applicable
25
Naples
2021-10-06
Active, closed
Novartis Pharmaceuticals
Phase 3
129
Roma, Naples
2021-10-05
Active, closed
Eli Lilly and Company
Phase 3
874
Naples, Aviano, Rome, Genoa, Florence, Padova
2021-10-04
Active, closed
A Non-interventional Cohort Safety Study of Patients With hATTR-PN
NCT04850105Hereditary Transthyretin Amyloidosis With Polyneuropthy
Akcea Therapeutics
Observational
202
Roma, Bologna, Genova, Messina, Milan, Naples, Pavia
2021-09-21
Recruiting
Novartis Pharmaceuticals
Phase 3
540
Bologna, Naples
2021-09-20
Active, closed
AstraZeneca
Phase 3
98
Florence, Meldola, Messina, Naples, Padova, Roma, Terni, Verona
2021-09-12
Active, closed
Nuvation Bio Inc.
Phase 2
217
Bari, Catania, Milan, Monserrato, Naples, Roma
2021-09-01
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Avellino, Naples, Bologna, Meldola, Reggio Emilia, Roma, Milan, Rozzano (MI)
2021-08-27
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
1,314
Bari, Campobasso, Catanzaro, Florence, Naples, Palermo, Pisa, Potenza
2021-08-25
Active, closed
Inventiva Pharma
Phase 3
1,000
San Giovanni Rotondo, Milan, Naples, Palermo, Roma, Bologna, Novara, Torino
2021-08-19
Recruiting
Merck Sharp & Dohme LLC
Phase 2
355
Naples, Milan, Siena, Bologna, Brescia, Verona
2021-08-12
Active, closed
Pfizer
Phase 3
118
Bergamo, Naples, Roma, Bologna
2021-08-12
Active, closed
HUYABIO International, LLC.
Phase 3
450
Milan, Perugia, Bari, Bologna, Misterbianco, Naples, Palermo, Roma
2021-08-12
Recruiting
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
NCT04913285Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Pierre Fabre Medicament
Phase 1
400
Naples
2021-08-04
Active, closed
Octapharma
Phase 3
50
Naples, Roma, Treviso
2021-08-04
Recruiting
Novartis Pharmaceuticals
Phase 1/2
222
Meldola, Milan, Naples, Reggio Emilia
2021-07-30
Active, closed
Boston Scientific Corporation
Not applicable
297
Brescia, Cotignola, Naples, Pisa
2021-07-20
Recruiting
Janssen Research & Development, LLC
Phase 3
199
Catania, Cefalù, Milan, Naples, Pavia, Roma
2021-07-15
Recruiting
Enterome
Phase 1/2
80
Bologna, Naples, Pavia
2021-07-05
Active, closed
Boehringer Ingelheim
Phase 1
554
Candiolo (TO), Naples, Parma
2021-07-02
Active, closed
AstraZeneca
Phase 3
315
Bergamo, Bologna, Florence, Meldola, Milan, Misterbianco, Naples, Padova
2021-06-30
Recruiting
Corcym S.r.l
Observational
2,150
Ancona, Bologna, Brescia, Lecce, Massa, Milan, Naples, Palermo
2021-06-29
Active, closed
Hoffmann-La Roche
Phase 3
142
Bari, Naples, Brescia, Monza, Turin
2021-06-25
Active, closed
Merck Sharp & Dohme LLC
Phase 2
302
Milan, Naples, Padova
2021-06-25
Active, closed
Neurocrine Biosciences
Phase 3
103
Bologna, Milan, Naples, Roma
2021-06-25
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Avellino, Biella, Cagliari, Candiolo, Lido di Camaiore, Meldola, Milan, Naples
2021-06-24
Active, closed
AstraZeneca
Phase 3
506
Ancona, Bergamo, Catania, Milan, Naples, Padova, Prato
2021-06-22
Recruiting
Pain ASsessment in CAncer Patients by Machine LEarning (PASCALE)
NCT04726228Oncology, Cancer Pain, Quality of Life
National Cancer Institute, Naples
Observational
40
Naples
2021-06-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Rome, Milan, Monza, Rozzano, Bari, Catania, Naples, Padova
2021-06-18
Active, closed
Janssen Research & Development, LLC
Phase 3
1,054
Catania, Milan, Naples, Palermo, Rome, Torino, Verona
2021-06-17
Recruiting
National Cancer Institute, Naples
Phase 2
35
Naples
2021-06-15
Active, closed
Daiichi Sankyo
Phase 2
155
Bergamo, Bologna, Monza, Naples, Perugia
2021-06-03
Recruiting
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
NCT04895709Cervical Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Microsatellite Stable Colorectal Cancer, Non-Small-Cell Lung Cancer
DrugsImzokitug·Pumitamig·Docetaxel·Nivolumab
Bristol-Myers Squibb
Phase 1/2
1,109
Rozzano, Candiolo, Milan, Naples, Roma, Siena
2021-05-27
Active, closed
Daiichi Sankyo
Phase 3
490
Barone, Candiolo, Catanzaro, Milan, Modena, Naples, Padua, Pisa
2021-05-21
Recruiting
Federico II University
Observational
200
Naples
2021-05-18
Active, closed
The SELUTION DeNovo Study
NCT04859985Coronary Artery Disease
M.A. Med Alliance S.A.
Not applicable
3,326
Alessandria, Naples, Torino, Vercelli
2021-05-15
Recruiting
Istituti Clinici Scientifici Maugeri SpA
Not applicable
100
Telese Terme, Naples
2021-05-15
Active, closed
Pfizer
Phase 3
599
Bologna, Cremona, Meldola, San Giovanni Rotondo, Naples, Aviano, Trento, Arezzo
2021-05-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
815
Monza, Milan, Rome, Naples
2021-05-12
Active, closed
Alfasigma S.p.A.
Observational
1,304
Bari, Brescia, Catania, Ferrara, Genova, Milan, Naples, Roma
2021-05-11
Active, closed
AstraZeneca
Phase 3
893
Bologna, Florence, Misterbianco, Naples, Padova, Prato, Roma
2021-05-10
By invitation
Cytokinetics
Phase 2/3
900
Florence, Milan, Naples, Pisa, Roma, Trieste
2021-05-06
Active, closed
Hoffmann-La Roche
Phase 2
586
Naples, Salerno, Bologna, Rome, Genoa, Brescia, Milan, Pozzilli (IS)
2021-05-05
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Avellino, Naples, Modena, Aviano, Rome, Brescia, Milan, Livorno
2021-05-04
Active, closed
Hoffmann-La Roche
Phase 3
761
Naples, Bologna, Meldola, Rome, Genoa, Milan, Orbassano, Arezzo
2021-05-03
Recruiting
Campania Registry On Peripheral Artery Disease
NCT04903912Peripheral Artery Disease
Federico II University
Observational
1,000
Naples
2021-05-01
Recruiting
Ipsen
Phase 1/2
240
Brescia, Naples, Rome, Verona
2021-04-29
Active, closed
AstraZeneca
Phase 3
1,157
Bergamo, Candiolo, Genova, Livorno, Milan, Naples, Padova, Rozzano
2021-04-26
Active, closed
Hoffmann-La Roche
Phase 3
557
Naples, Bologna, Rome, Milan, Turin, Palermo, Florence, Pisa
2021-04-26
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
NCT04752722Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Non-muscle Invasive Bladder Cancer
DrugPhase 2
enGene, Inc.
Phase 1/2
350
Milan, Naples, Rome, Torino
2021-04-22
Active, closed
Incyte Corporation
Phase 3
654
Bari, Brescia, Candiolo, Catania, Lecce, Milan, Naples, Novara
2021-04-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,688
Modena, Rome, Bari, Milan, Naples, Terni
2021-04-14
Active, closed
Eli Lilly and Company
Phase 3
101
Naples, Genoa, Milan, Florence, Brescia
2021-04-13
Recruiting
Gilead Sciences
Phase 1
30
Milan, Naples
2021-04-06
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
DrugNemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
490
Bari, Bologna, Brescia, Milan, Naples, Pavia, Reggio Emilia, Roma
2021-04-05
Active, closed
Kedrion S.p.A.
Phase 3
30
Brescia, Florence, Genova, Milan, Naples, Roma
2021-03-31
Active, closed
Hoffmann-La Roche
Phase 3
751
Chieti, Bari, Naples, Rome, Genoa, Milan, Montichiari, Pavia
2021-03-24
Active, closed
Hoffmann-La Roche
Phase 3
746
Foggia, Naples, Parma, Rome, Bergamo, Milan, Mondovì (CN), Catania
2021-03-17
Recruiting
AstraZeneca
Phase 1
304
Milan, Monza, Naples, Padova
2021-03-09
Recruiting
Istituti Clinici Scientifici Maugeri SpA
Not applicable
60
Telese Terme, Naples
2021-03-04
Active, closed
Bioverativ, a Sanofi company
Phase 3
261
Naples, Milan, Vicenza
2021-02-23
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase 4
50
Bologna, Naples, Padova
2021-02-23
Recruiting
Biosense Webster, Inc.
Observational
8,000
Acquaviva delle Fonti, Ancona, Milan, Naples
2021-02-22
Recruiting
Centro Cardiologico Monzino
Observational
10,000
Milan, Ancona, Bari, Bergamo, Brescia, Foggia, Naples, Palermo
2021-02-10
Active, closed
Fondazione Melanoma Onlus
Phase 2
25
Bergamo, Bagno a Ripoli, Meldola, Milan, Naples, Padova, Brescia
2021-02-10
Active, closed
Hoffmann-La Roche
Phase 3
55
Naples, Parma, Milan, Florence
2021-02-04
Active, closed
AstraZeneca
Phase 3
1,371
Bergamo, Florence, Milan, Modena, Naples, Novara, Padova, Parma
2021-01-28
Active, closed
National Cancer Institute, Naples
Not applicable
47
Naples
2021-01-18
Active, closed
Galderma R&D
Phase 3
500
Catania, Chieti, Genova, L’Aquila, Modena, Naples, Parma, Perugia
2021-01-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
990
Roma, Rome, Milan, Candiolo, Brescia, Naples, Padova
2021-01-10
Active, closed
Amgen
Phase 1/2
181
Bergamo, Bologna, Brescia, Catania, Milan, Naples, Roma
2021-01-04
Active, closed
A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations
NCT04639219Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
DrugTrastuzumab deruxtecan
AstraZeneca
Phase 2
102
Milan, Naples
2020-12-30
Active, closed
AstraZeneca
Phase 1/2
245
Bologna, Milan, Naples, Rome
2020-12-28
Active, closed
Pfizer
Phase 3
841
Monserrato (CA), San Giovanni Rotondo, Milan, Candiolo, Orbassano, Brescia, Naples, Padova
2020-12-21
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2
182
Bologna, Milan, Monza, Naples, Padova
2020-12-18
Active, closed
Neurocrine Biosciences
Phase 3
182
Ancona, Bologna, Florence, Messina, Milan, Naples, Padova, Roma
2020-12-16
Active, closed
Atrasentan in Patients With IgA Nephropathy
NCT04573478IgA Nephropathy, Immunoglobulin A Nephropathy
DrugsAtrasentan·Zigakibart
Novartis Pharmaceuticals
Phase 3
404
Milan, Genova, Naples, Pavia
2020-12-11
Active, closed
GlaxoSmithKline
Phase 2/3
758
Ancona, Avellino, Florence, Milan, Monza, Naples, Orbassano to, Perugia
2020-12-08
Active, closed
MeiraGTx Ocular UK Ltd
Phase 3
97
Florence, Milan, Naples, Rome
2020-12-04
Active, closed
Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapy
NCT04463641Heart Failure, Cardiac Resynchronization Therapy
MicroPort CRM
Not applicable
92
Brescia, Naples
2020-12-03
Active, closed
Hoffmann-La Roche
Phase 3
769
Naples, Rome, Gallarate, Milan, Pavia, Turin
2020-12-03
Active, closed
Fondazione Melanoma Onlus
Phase 2
95
Bagno a Ripoli, Meldola, Milan, Naples, Padova, Genova
2020-12-03
Active, closed
Weizmann Institute of Science
Observational
267
Naples
2020-11-29
Active, closed
Hoffmann-La Roche
Phase 3
864
Chieti, Naples, Rome, Milan, Pozzilli
2020-11-26
Recruiting
Alnylam Pharmaceuticals
Observational
1,500
Milan, Naples, Palermo, Roma
2020-11-23
Active, closed
AstraZeneca
Phase 1/2
702
Milan, Modena, Naples, Padova, Roma
2020-11-12
Active, closed
Novartis Pharmaceuticals
Phase 2
134
Milan, Naples
2020-10-30
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
NCT04585750Advanced Solid Tumor, Advanced Malignant Neoplasm, Metastatic Cancer, Metastatic Solid Tumor
DrugsRezatapopt·Keytruda·Pembrolizumab
PMV Pharmaceuticals, Inc
Phase 1/2
300
Rome, Milan, Rozzano, Candiolo, Naples
2020-10-29
Active, closed
Hoffmann-La Roche
Phase 3
985
Naples, Parma, Rome, Genoa, Milan, Montichiari, Pozzilli, Palermo
2020-10-26
Active, closed
Bayer
Phase 3
402
Naples, Parma, Orbassano, Turin, Padova
2020-10-20
Active, closed
AstraZeneca
Phase 3
370
Brescia, Candiolo, Florence, Milan, Modena, Naples, Padova
2020-10-02
Active, closed
A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)
NCT04093349Pompe Disease, Pompe Disease (Late-onset), Glycogen Storage Disease Type 2, Glycogen Storage Disease Type II
Spark Therapeutics, Inc.
Phase 1/2
4
Messina, Milan, Naples, Pisa, Torino
2020-10-01
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Avellino, Catania, Meldola, Milan, Monza, Naples, Orbassano, Ravenna
2020-09-30
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Arezzo, Candiolo, Cremona, Lecce, Meldola, Milan, Naples, Orbassano
2020-09-23
Active, closed
Daiichi Sankyo
Phase 1
145
Milan, Monza, Naples
2020-09-15
Active, closed
AbbVie
Phase 3
531
Rozzano, Naples, Rome, Bologna, Reggio Calabria
2020-09-10
Active, closed
Karyopharm Therapeutics Inc
Phase 2/3
501
Ancona, Caserta, Naples, Novara, Pescara, Rome, Palermo, Turin
2020-09-03
Active, closed
AbbVie
Phase 3
330
Bologna, Florence, Rome, Monza, Naples, Turin, Ancona, Bergamo
2020-08-31
Recruiting
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
NCT04421820Colorectal Cancer, Pancreatic Cancer, Gastric Cancers, Cholangiocarcinoma
DrugsFolfox·Oxaliplatin
Bold Therapeutics, Inc.
Phase 1/2
220
Milan, Naples, Pisa
2020-08-28
Active, closed
Abbott Medical Devices
Observational
511
Cotignola, Naples
2020-08-27
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
125
Naples, Pavia, Pisa, Roma
2020-08-25
Recruiting
Nordic Lymphoma Group
Phase 3
300
Aviano, Bari, Calabria, Monza, Naples, Roma, Segrate, Trieste
2020-08-19
Active, closed
Pfizer
Phase 3
77
Roma, Florence, Naples
2020-08-18
Active, closed
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
NCT04482309Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer, Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
DrugTrastuzumab deruxtecan
AstraZeneca
Phase 2
477
Milan, Naples, Rome
2020-08-18
Active, closed
Incyte Corporation
Phase 2
112
Bologna, Florence, Meldola (FC), Milan, Naples, Novara, Palermo, Pisa
2020-08-03
Recruiting
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib
NCT03651206Ovarian Carcinosarcoma, Endometrial Carcinosarcoma
DrugNiraparib
ARCAGY/ GINECO GROUP
Phase 2/3
138
Bologna, Catania, Meldola, Milan, Naples, Roma, Torino
2020-07-15
Active, closed
Celgene
Phase 2
276
Bergamo, Naples
2020-07-14
Active, closed
GlaxoSmithKline
Phase 3
242
Milan, Modena, Monza, Naples, Negrar Verona, Padova, Palermo, Roma
2020-07-14
Active, closed
Shanghai Junshi Bioscience Co., Ltd.
Phase 3
530
Milan, Naples, Pisa, Tortona, Verona
2020-06-29
Active, closed
Epizyme, Inc.
Phase 3
599
Naples, Meldola, Brescia, Catania, Florence, Lecce, Milan, Monza
2020-06-11
Active, closed
AstraZeneca
Phase 2
452
Milan, Naples, Padova, Roma, Verona
2020-06-03
Active, closed
"Sleep Patterns and EEG Structure in Youth With Autism: Links With Behavior and Parental Stress"
NCT07122388Sleep Disorder (Disorder), Autism Spectrum Disorder
University of Campania Luigi Vanvitelli
Observational
187
Naples
2020-06-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
520
Bari, Rome, Milan, Florence, Modena, Naples, Province of Macerata
2020-05-19
Recruiting
EORTC Metastatic Breast Cancer Module Development
NCT07806266Metastatic Beast Cancer
University of Leeds
Observational
568
Naples, Padova
2020-05-01
Active, closed
AstraZeneca
Phase 2
240
Bologna, Catanzaro, Meldola, Messina, Milan, Monza, Naples, Roma
2020-04-22
Active, closed
AstraZeneca
Phase 3
818
Bergamo, Candiolo, Catanzaro, Livorno, Meldola, Milan, Modena, Naples
2020-04-16
Recruiting
Covid-19 in Hematological Malignancies
NCT04733729COVID-19 Infection in Hematological Malignancies Patients
Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne
Observational
3,000
Brescia, Naples, Rome, Varese, Verona
2020-03-01
Active, closed
Immunocore Ltd
Phase 1/2
410
Rome, Seriate, Naples
2020-02-25
Active, closed
Eli Lilly and Company
Phase 3
261
Naples, Ravenna, Aviano, Rome, Monza, Milan, Rozzano, Orbassano
2020-02-17
Active, closed
Eli Lilly and Company
Phase 3
58
Brescia, Chieti, Genova, Milan, Naples, Palermo, Trieste
2020-02-12
Active, closed
Loxo Oncology, Inc.
Phase 3
291
Naples, Rome, Milan, Turin, Pisa, Siena, Padova, Catania
2020-02-11
Recruiting
Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening Ischemia
NCT06277362Peripheral Arterial Disease, Critical Limb-Threatening Ischemia, Diabetic Foot
EndoCore Lab s.r.l.
Observational
50
Ancona, Belluno, Cesena, Conegliano, Naples, Reggio Emilia, Trento, Perugia
2020-01-31
Recruiting
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
NCT03934372Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia
DrugPonatinib
Incyte Biosciences International Sàrl
Phase 1/2
70
Bologna, Brescia, Genova, Milan, Monza, Naples, Pavia, Rome
2020-01-29
Active, closed
Takeda
Phase 3
354
Naples, Meldola, Milan, Orbassano, Aviano, Pisa, Parma, Ravenna
2020-01-10
Active, closed
Advanced Accelerator Applications
Phase 3
226
Bologna, Genova, Meldola, Milan, Naples, Reggio Emilia, Roma
2020-01-08
Active, closed
Gruppo Italiano Trapianto di Midollo Osseo
Phase 2
120
Cagliari, Naples, Ancona, Bari, Bologna, Brescia, Cuneo, Florence
2019-12-06
Recruiting
Alexion Pharmaceuticals, Inc.
Observational
500
Milan, Naples
2019-12-02
Recruiting
Celgene
Phase 2
99
Rome, Genoa, Naples, Orbassano
2019-11-07
Active, closed
Novartis Pharmaceuticals
Phase 1
120
Milan, Rozzano, Modena, Aviano, Siena, Naples
2019-10-30
Active, closed
AstraZeneca
Phase 3
140
Cuneo, Florence, Milan, Naples, Roma, Torino
2019-10-29
Active, closed
Bristol-Myers Squibb
Phase 3
790
Palermo, Bergamo, Milan, Naples, Padova, Perugia, Siena
2019-10-28
Active, closed
Biogen
Phase 3
152
Florence, Naples
2019-10-18
Recruiting
Study on Gynecological Rare Cancers
NCT05733806Gynecologic Cancer
National Cancer Institute, Naples
Observational
500
Milan, Naples
2019-10-14
Active, closed
NeuroDerm Ltd.
Phase 3
381
Arcugnano, Cassino, Chieti, Grosseto, Milan, Naples, Pavia, Roma
2019-09-30
Recruiting
National Cancer Institute, Naples
Phase 2
34
Naples
2019-09-05
Active, closed
Janssen Research & Development, LLC
Phase 1
701
Milan, Monza, Naples, Ravenna
2019-09-04
Recruiting
Centro di Riferimento Oncologico - Aviano
Observational
78
Aviano, Genova, Messina, Milan, Modena, Naples, Reggio Emilia, Roma
2019-08-27
Active, closed
Sanofi
Observational
1,860
Terracina, Naples, Padua, Bari, Bologna, Brescia, Catania, Milan
2019-08-15
Active, closed
Hoffmann-La Roche
Phase 1/2
498
Naples, Bergamo, Milan, Rozzano
2019-08-13
Active, closed
Hoffmann-La Roche
Phase 3
1,013
Naples, Rome, Genoa, Milan, Pavia, Orbassano, Cefalù
2019-08-12
Active, closed
Bristol-Myers Squibb
Phase 3
839
Catania, Genova, Milan, Naples, Padova, Roma
2019-08-05
Active, closed
OncoVerity, Inc.
Phase 2
103
Bologna, Brescia, Meldola, Milan, Naples, Udine
2019-07-29
Active, closed
Pfizer
Phase 3
51
Florence, Naples
2019-07-29
Active, closed
Novartis Pharmaceuticals
Phase 3
254
Genova, Milan, Verona, Naples
2019-07-26
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
Roma, Orbassano, Vicenza, Arezzo, Catania, Milan, Naples, Pavia
2019-07-24
Active, closed
Tesaro, Inc.
Phase 3
785
Candiolo, Carpi MO, Lecce, Milan, Naples, Ponderano BI, Rome, Sassuolo
2019-07-18
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
197
Bergamo, Milan, Naples
2019-07-17
Active, closed
Development of a Web-based Multicenter Registry on the Use of oXiris Membrane for EBPTs in Critically Ill Patients
NCT03807414Critical Illness, Acute Kidney Injury, Sepsis, Systemic Inflammatory Response Syndrome
Careggi Hospital
Observational
270
Esine, Empoli, San Donato Milanese, Benevento, Florence, Naples, Pavia, Perugia
2019-06-28
Active, closed
AstraZeneca
Phase 2
247
Catania, Naples, Orbassano, Padova, Varese
2019-06-25
Active, closed
Regeneron Pharmaceuticals
Phase 3
415
Bergamo, Bologna, Brescia, Florence, L’Aquila, Milan, Naples, Rome
2019-06-04
Active, closed
Celgene
Phase 1/2
438
Bergamo, Bologna, Milan, Naples, Pavia
2019-05-20
Active, closed
AstraZeneca
Phase 3
810
Faenza, Florence, Milan, Naples, Roma, Verona
2019-04-16
Recruiting
Eli Lilly and Company
Phase 3
190
Brescia, Chieti, Genova, Milan, Naples, Palermo, Trieste
2019-04-05
Active, closed
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)
NCT03913143Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis, Vision Disorders
DrugSepofarsen
ProQR Therapeutics
Phase 2/3
36
Naples
2019-04-04
Active, closed
Eisai Inc.
Phase 3
1,906
Tricase, Cefalù, Genova, Milan, Monza, Naples, Perugia, Pisa
2019-03-27
Active, closed
Avelumab Program Rollover Study
NCT03815643Solid Tumors
DrugAvelumab
EMD Serono Research & Development Institute, Inc.
Phase 3
205
Naples, Padova, Roma, Rozzano
2019-03-22
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Cagliari, Cremona, Naples, Padova, Pisa, Potenza, Reggio Emilia, Roma
2019-03-21
Active, closed
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
NCT03845166Neoplasm Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer
DrugsZanzalintinib·Avelumab·Tecentriq·Atezolizumab
Exelixis
Phase 1
325
Milan, Pavia, Naples
2019-03-20
Active, closed
Novartis Pharmaceuticals
Phase 2
22
Pavia, Roma, Torino, Naples
2019-03-13
Recruiting
Abbott Medical Devices
Observational
2,000
Naples, Pavia
2019-03-13
Active, closed
Follow-up in Gynecological Cancer Survivors
NCT03515993Gynecologic Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Observational
1,100
Monza, Naples, Torino
2019-02-21
Active, closed
NVT GmbH
Observational
346
Milan, Naples
2019-02-20
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Faenza, Milan, Naples, Padova, Parma, Perugia, Pisa, Roma
2019-01-25
Recruiting
RECORDATI GROUP
Observational
95
Florence, Milan, Monza, Naples, Padova, Turin
2019-01-15
Active, closed
AstraZeneca
Phase 3
1,407
Brescia, Lecce, Lecco, Milan, Mirano, Naples, Reggio Calabria, Reggio Emilia
2019-01-04
Active, closed
Merck Sharp & Dohme LLC
Phase 2
329
Naples, Rozzano, Siena
2018-12-12
Active, closed
AstraZeneca
Phase 3
1,063
Bari, Bologna, Florence, Milan, Naples, Orbassano, Pozzuoli, Verona
2018-11-16
Active, closed
AstraZeneca
Phase 3
895
Milan, Naples, Orbassano, Pavia
2018-10-31
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
271
Bergamo, Naples, Padova, Roma, Siena, Turin, Udine
2018-10-30
Active, closed
Tesaro, Inc.
Phase 3
1,400
Bologna, Faenza, Lugo RA, Meldola FC, Naples
2018-10-11
Active, closed
AbbVie
Phase 2
270
Bologna, Meldola, Milan, Naples, Rome, Orbassano, Avellino, Parma
2018-10-10
Active, closed
AstraZeneca
Phase 3
1,246
Arezzo, Milan, Naples, Orbassano, Parma, Pavia, Roma, Terni
2018-09-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Meldola, Bari, Bergamo, Genova, Milan, Naples, Padova, Roma
2018-09-12
Active, closed
Hoffmann-La Roche
Phase 3
257
Naples, Rome, Milan, Orbassano, Perugia
2018-08-16
Active, closed
AbbVie
Phase 3
1,533
Rome, Rozzano, Ancona, Catania, Milan, Naples
2018-08-09
Recruiting
Celgene
Phase 2/3
1,541
Ancona, Bologna, Milan, Monza, Naples, Roma, Rome, Rozzano (MI)
2018-07-19
Recruiting
Xynomic Pharmaceuticals, Inc.
Phase 3
413
Candiolo, Catania, Meldola (FC), Milan, Naples, Novara, Pavia, Pisa
2018-07-17
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer
NCT03505320Pharmacokinetics of Zolbetuximab, Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer, Pharmacokinetics of Oxaliplatin
DrugsZolbetuximab·Folinic acid·Fluorouracil·Leucovorin
Astellas Pharma Global Development, Inc.
Phase 2
143
Milan, Naples, Padova, Pisa
2018-06-29
Active, closed
Exelixis
Phase 3
837
Tricase, Rozzano, Bologna, Brescia, Milan, Naples, Novara, Roma
2018-06-10
Active, closed
Hoffmann-La Roche
Phase 3
927
Bari, Naples, Trieste, Rome, Genoa, Milan, Pavia, Pozzilli
2018-05-28
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
890
Rome, Milan, Naples
2018-05-21
Active, closed
pharmaand GmbH
Phase 3
1,097
Aviano, Candiolo, Catania, Chieti, Naples, Roma, Vicenza
2018-05-14
Active, closed
Hoffmann-La Roche
Phase 1/2
211
Naples, Bologna, Bergamo, Milan
2018-05-08
Active, closed
Corcept Therapeutics
Phase 2
125
Ancona, Messina, Milan, Naples, Padova, Torino
2018-05-07
Active, closed
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF), Primary Myelofibrosis (PMF), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
GlaxoSmithKline
Phase 2
237
Bologna, Florence, Genova, Milan, Monza, Naples, Pesaro, Rionero in Vulture PZ
2018-05-03
Active, closed
PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases
NCT03569241Prostate Cancer, Prostate Cancer Metastatic, Metastatic Cancer, Oligometastatic Cancer
University Hospital, Ghent
Phase 2
196
Milan, Naples, Pavia, Verona
2018-04-27
By invitation
International Registry of Congenital Portosystemic Shunt (IRCPSS)
NCT06041906Congenital Portosystemic Shunt, CPSS (Congenital Portosystemic Shunt)
Prof. Valérie Mc Lin
Observational
500
Bergamo, Naples, Palermo
2018-04-26
Active, closed
Merck Sharp & Dohme LLC
Phase 3
797
Milano, Naples, Meldola, Rozzano, Milan, Monza, Orbassano, Brescia
2018-04-24
Active, closed
MedImmune LLC
Phase 1
400
Meldola, Naples, Ravenna, Roma
2018-04-24
Active, closed
Pyruvate Kinase Deficiency Global Longitudinal Registry
NCT03481738Pyruvate Kinase Deficiency
Agios Pharmaceuticals, Inc.
Observational
500
Pescara, Naples, Genoa, Milan, Roma
2018-04-23
Active, closed
Bristol-Myers Squibb
Phase 3
545
Messina, Bologna, Florence, Meldola, Milan, Modena, Monserrato, Naples
2018-04-18
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
Turin, Bergamo, Milan, Naples, Padova, Siena
2018-04-11
Active, closed
Merck Sharp & Dohme LLC
Phase 2
340
Roma, Aviano, Naples, Torino
2018-04-09
Recruiting
Gene Therapy for Severe Crigler Najjar Syndrome
NCT03466463Crigler-Najjar Syndrome
Genethon
Not applicable
17
Bergamo, Naples
2018-03-19
Active, closed
Janssen Research & Development, LLC
Phase 2
136
Florence, Lecce, Milan, Naples, Province of Macerata
2018-03-02
Active, closed
Federico II University
Not applicable
120
Naples
2018-02-02
Recruiting
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
NCT03142152Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency, Heart Diseases
Cardiac Dimensions, Inc.
Not applicable
300
Naples, Roma
2018-01-01
Active, closed
Pfizer
Phase 3
1,054
Bologna, Cremona, Meldola, Terni, Trento, Orbassano, Naples
2017-12-18
Active, closed
CUTISS AG
Phase 2
12
Milan, Naples
2017-10-25
Active, closed
AstraZeneca
Phase 3
1,324
Benevento, Meldola, Milan, Naples, Perugia, Pisa, Roma, Rozzano
2017-10-11
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
Naples, Meldola, Aviano, Rome, Bergamo, Cremona, Milan, Monza
2017-09-22
Active, closed
Hoffmann-La Roche
Phase 3
382
Naples, Modena, Rome, Genoa, Milan, Monza, Novara, Orbassano
2017-09-20
Active, closed
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
NCT03170960Urothelial Carcinoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Castration-resistant Prostate Cancer
DrugsCabozantinib·Tecentriq·Atezolizumab
Exelixis
Phase 1
914
Meldola, Rozzano, Milan, Naples, Pavia, Roma
2017-09-05
Active, closed
Eli Lilly and Company
Phase 3
5,637
Naples, Cona, Meldola, Monza, Milan, Rozzano, Rome, Terni
2017-07-12
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugPacritinib
Swedish Orphan Biovitrum
Phase 3
407
Bari, Bologna, Brescia, Florence, Forlì, Milan, Monza, Naples
2017-06-26
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
Alessandria, Bologna, Brescia, Cremona, Genova, Legnago, Milan, Naples
2017-05-03
Active, closed
Bristol-Myers Squibb
Phase 3
1,314
Arezzo, Faenza, Forlì, Grosseto, Milan, Naples
2017-03-24
Active, closed
AbbVie
Phase 3
443
Lecce, Rome, Ancona, Bergamo, Bologna, Genova, Milan, Naples
2017-02-02
Recruiting
Non-Immunoglobulin E-mediated Food Allergies in Children
NCT04462978Non IgE Mediated Food Allergy, Food Protein-Induced Enteropathy, Food Protein-Induced Proctocolitis, Food Protein-Induced Enterocolitis Syndrome
Federico II University
Observational
150
Naples
2017-01-01
Recruiting
National Eye Institute (NEI)
Observational
5,000
Naples
2016-10-04
Active, closed
Eli Lilly and Company
Phase 2
234
Roma, Negrar, Bologna, Naples
2016-09-14
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
DrugTepotinib
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Genova, Milan, Naples, Padova, Roma, Rozzano
2016-09-13
Recruiting
Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment
NCT03760835Congenital Adrenal Hyperplasia
Federico II University
Phase 4
150
Naples
2016-08-11
Active, closed
Tesaro, Inc.
Phase 3
733
Lecce, Milan, Modena, Naples
2016-07-11
Active, closed
Philogen S.p.A.
Phase 3
214
Genova, Milan, Padova, Naples, Siena, Trieste, Turin
2016-07-01
Active, closed
AGO Study Group
Not applicable
797
Milan, Naples
2016-07
Active, closed
Tesaro, Inc.
Phase 1
729
Milan, Modena, Naples, Roma, Verona
2016-03-07
Recruiting
University of Campania Luigi Vanvitelli
Phase 4
150
Naples
2016-01
Active, closed
HyaloFAST Trial for Repair of Articular Cartilage in the Knee
NCT02659215Defect of Articular Cartilage
Anika Therapeutics, Inc.
Not applicable
200
Bologna, Genova, Naples
2015-12
Active, closed
Hoffmann-La Roche
Phase 2
534
Naples, Rome, Milan, Pisa, Perugia, Padova
2015-11-19
Active, closed
AstraZeneca
Phase 3
1,126
Arezzo, Meldola, Milan, Naples, Orbassano, Pavia, Roma, San Giovanni Rotondo
2015-11-02
Recruiting
EffecTAVI Registry
NCT05235555Aortic Stenosis, Transcatheter Aortic Valve Replacement, TAVI
Federico II University
Observational
1,000
Naples
2015-09-01
Active, closed
Ischaemic PReconditioning In Non Cardiac surgEry
NCT02427867Myocardial Ischemia, Surgery
Università Vita-Salute San Raffaele
Not applicable
1,217
Rozzano, Busto Arsizio, Asti, Florence, Genova, Milan, Naples, Pisa
2015-04
Recruiting
Monaldi Hospital Rhythm Registry
NCT05072119Pacemaker, ICD, Implanted Loop Recorder
University of Campania Luigi Vanvitelli
Observational
5,000
Naples
2015-01-07
Recruiting
CAMpania PugliA bRanch Iliaco
NCT06946381Aortoiliac Aneurysm, Iliac Aneurysm
Federico II University
Observational
200
Bari, Naples
2015-01-01
Active, closed
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
DrugsLupron·Eligard·Leuprorelin·Xtandi
Pfizer
Phase 3
1,068
Roma, Cremona, Faenza RA, Lugo RA, Meldola (FC), Naples, Orbassano (TO), Ravenna
2014-12-17
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Bologna, Florence, Naples, Novara, Rome, Siena, Torino
2014-11
Recruiting
Arrhythmias Detection in a Real World Population
NCT02275637Appropriate and Inappropriate Shock Therapy With ICD, Arrhythmias Detection
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
10,000
Bergamo, Bologna, Catania, Florence, Milan, Naples, Padua, Pavia
2014-09
Active, closed
AbbVie
Observational
1,446
Milan, Rome, Bologna, Messina, Naples, Palermo, Parma, Pescara
2014-08-28
Recruiting
Weill Medical College of Cornell University
Not applicable
600
Florence, Rozzano, Naples
2014-03-12
Recruiting
Registro Campania Salute Network on Hypertension
NCT02211365Hypertension; Heart Disease, Hypertensive
Federico II University
Observational
10,000
Naples
2014-02
Active, closed
International Bicuspid Aortic Valve Consortium (BAVCon)
NCT01980797Bicuspid Aortic Valve Disease, Thoracic Aortic Disease in Patients With a Bicuspid Aortic Valve
Boston University
Observational
6,464
San Donato Milanese, Naples, Salerno
2013-11
Active, closed
AstraZeneca
Phase 3
510
Bari, Genova, Livorno, Milan, Naples, Orbassano, Parma, Perugia
2013-09-25
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
DrugOlaparib
AstraZeneca
Phase 3
327
Milan, Modena, Naples, Padova, Roma
2013-09-03
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
DrugOlaparib
AstraZeneca
Phase 3
450
Bari, Catania, Milan, Naples, Padova, Roma
2013-08-26
Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
NCT01633489Lysosomal Acid Lipase Deficiency, Cholesterol Ester Storage Disease, Wolman Disease, Acid Cholesteryl Ester Hydrolase Deficiency, Type 2
Alexion Pharmaceuticals, Inc.
Observational
300
Bari, Naples, Udine, Genoa, Bergamo, Milan, Turin, Florence
2013-05-30
Active, closed
AbbVie
Observational
8,250
Bologna, Florence, San Giovanni Rotondo, Genoa, Rozzano, Milan, Naples, Rome
2013-04-29
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Bologna, Florence, Genoa, Monza, Naples, Padova, Pavia, Pisa
2013-04
Active, closed
Bristol-Myers Squibb
Observational
800
Florence, Genova, Naples, Padova, Trento
2013-01-30
Recruiting
CHDI Foundation, Inc.
Observational
35,000
Milan, Bari, Bologna, Genoa, Naples, Rome
2012-07
Active, closed
Bristol-Myers Squibb
Observational
2,555
Pesaro, Ancona, Cagliari, Florence, Lecce, Messina, Milan, Naples
2012-06-13
Recruiting
Patient Retrospective Outcomes (PRO)
NCT01550575Chronic Pain
Boston Scientific Corporation
Observational
15,000
Alessandria, Naples, Ravenna, Rionero in Vulture, Rome, Verona
2012-04-03
Active, closed
Sentinel Node Vs Observation After Axillary Ultra-souND
NCT02167490Early Stage Breast Carcinoma
European Institute of Oncology
Not applicable
1,560
Bolzano, Brescia, Cagliari, Castellanza, Como, Mantua, Milan, Naples
2012-01
Active, closed
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
NCT01385176Heart Failure, Congestive Heart Failure
Boston Scientific Corporation
Not applicable
118
Milan, Naples, Pavia
2011-09-21
Recruiting
Azienda Ospedaliero-Universitaria di Parma
Observational
1,000
Milan, Palermo, Parma, Urbino, Bologna, Carrara, Genova, Naples
2010-09
Recruiting
Sporadic Degenerative Ataxia With Adult Onset: Natural History Study
NCT02701036Late Onset Sporadic Cerebellar Ataxia
Ataxia Study Group
Observational
300
Naples, Rome
2010-04
Active, closed
Minimal SN Tumor Burden
NCT01942603Cutaneous Melanoma
European Organisation for Research and Treatment of Cancer - EORTC
Observational
296
Milan, Naples, Padova
2009-07
Recruiting
Esteve Pharmaceuticals, S.A.
Observational
500
Ancona, Bolzano, Brescia, Florence, Genova, Naples, Parma, Province of Macerata
2008-12-09
Active, closed
Genentech, Inc.
Phase 2
378
Potenza, Catanzaro, Naples, Meldola, Parma, Aviano (PN), Udine, Milan
2008-10-16
Recruiting
The EUROSCA Natural History Study
NCT02440763Spinocerebellar Ataxia
Ataxia Study Group
Observational
400
Milan, Naples
2005-07
Recruiting
Manuel Monreal
Observational
120,000
Avezzano, Belluno, Brescia, Avellino, Naples, Marcianise, Castelfranco, Cremona
2001-03
By invitation
Copenhagen University Hospital, Rigshospitalet
Observational
23,000
Bergamo, Milan, Modena, Naples, Rome
1994-01
Rows per page Showing 501–983 of 983
Previous 1 2
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/naples?page=2

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 983 of those studies with a site in Naples.

How many clinical trials are recruiting in Naples?

509 of the 983 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 40 have not yet opened recruitment, 417 are active but closed to new participants, and 17 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.